{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T08:36:58Z","timestamp":1762418218326,"version":"build-2065373602"},"reference-count":23,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.remn.2020.03.010","type":"journal-article","created":{"date-parts":[[2020,5,25]],"date-time":"2020-05-25T16:53:51Z","timestamp":1590425631000},"page":"284-291","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Utilidad diagn\u00f3stica e impacto terap\u00e9utico de la PET\/TC con [18F]F-Fluormetilcolina en la recidiva bioqu\u00edmica del c\u00e1ncer de pr\u00f3stata"],"prefix":"10.1016","volume":"39","author":[{"given":"N.","family":"S\u00e1nchez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Valduvieco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.J.","family":"Ribal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Campos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Casas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Nicolau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Salvador","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Mellado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Jorcano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Fuster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Paredes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.remn.2020.03.010_bib0120","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.eururo.2012.01.022","article-title":"Cancer control and functional outcomes of salvage radical prostatectomy for radiation-recurrent prostate cancer: a systematic review of the literature","volume":"61","author":"Chade","year":"2012","journal-title":"Eur Urol."},{"key":"10.1016\/j.remn.2020.03.010_bib0125","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.eururo.2019.09.020","article-title":"EAU-EANM-ESTRO-ESUR-SIOG Prostate Cancer Guideline Panel Consensus Statements for Deferred Treatment with Curative Intent for Localised Prostate Cancer from an International Collaborative Study (DETECTIVE Study)","volume":"76","author":"Lam","year":"2019","journal-title":"Eur Urol."},{"key":"10.1016\/j.remn.2020.03.010_bib0130","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1146\/annurev.nu.01.070181.000523","article-title":"Dietary choline: biochemistry, physiology, and pharmacology","volume":"1","author":"Zeisel","year":"1981","journal-title":"Annu Rev Nutr."},{"key":"10.1016\/j.remn.2020.03.010_bib0135","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/MNM.0000000000000040","article-title":"Meta-analysis of 11 C-choline and 18 F-choline PET \/CT for management of patients with prostate cancer","volume":"35","author":"Von Eyben","year":"2013","journal-title":"Nucl Med Commun."},{"key":"10.1016\/j.remn.2020.03.010_bib0140","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/COC.0000000000000139","article-title":"Does Choline PET\/CT change the management of prostate cancer patients with biochemical failure?","volume":"40","author":"Goldstein","year":"2017","journal-title":"Am J Clin Oncol."},{"key":"10.1016\/j.remn.2020.03.010_bib0145","doi-asserted-by":"crossref","first-page":"567","DOI":"10.3349\/ymj.2018.59.5.567","article-title":"Treatment of oligometastatic hormone-sensitive prostate cancer: a comprehensive review","volume":"59","author":"Koo","year":"2018","journal-title":"Yonsei Med J."},{"key":"10.1016\/j.remn.2020.03.010_bib0150","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s00330-008-1174-8","article-title":"Endorectal magnetic resonance imaging at 1.5 Tesla to assess local recurrence following radical prostatectomy using T2-weighted and contrast-enhanced imaging","volume":"19","author":"Cirillo","year":"2009","journal-title":"Eur Radiol."},{"key":"10.1016\/j.remn.2020.03.010_bib0155","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.2214\/AJR.07.3032","article-title":"Endorectal and dynamic contrast-enhanced MRI for detection of local recurrence after radical prostatectomy","volume":"190","author":"Casciani","year":"2008","journal-title":"AJR Am J Roentgenol."},{"key":"10.1016\/j.remn.2020.03.010_bib0160","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.eururo.2007.12.034","article-title":"Role of dynamic contrast-enhanced Magnetic Resonance (MR) Imaging and Proton MR Spectroscopic Imaging in the detection of local recurrence after radical prostatectomy for prostate cancer","volume":"54","author":"Sciarra","year":"2008","journal-title":"Eur Urol."},{"key":"10.1016\/j.remn.2020.03.010_bib0165","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.eururo.2013.05.025","article-title":"Management of biochemical recurrence after primary treatment of prostate cancer: a systematic review of the literature","volume":"64","author":"Punnen","year":"2013","journal-title":"Eur Urol."},{"key":"10.1016\/j.remn.2020.03.010_bib0170","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.2967\/jnumed.108.061507","article-title":"Influence of trigger PSA and PSA kinetics on 11C-Choline PET\/CT detection rate in patients with biochemical relapse after radical prostatectomy","volume":"50","author":"Castellucci","year":"2009","journal-title":"J Nucl Med."},{"key":"10.1016\/j.remn.2020.03.010_bib0175","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s00259-011-2030-7","article-title":"Influence of PSA PSA velocity and PSA doubling time on contrast-enhanced 18F-choline PET\/CT detection rate in patients with rising PSA after radical prostatectomy","volume":"39","author":"Schillaci","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"10.1016\/j.remn.2020.03.010_bib0180","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1007\/s00259-015-3306-0","article-title":"PET\/CT with (18)F-choline after radical prostatectomy in patients with PSA \u22642\u00a0ng\/ml. Can PSA velocity and PSA doubling time help in patient selection?","volume":"43","author":"Chiaravalloti","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"10.1016\/j.remn.2020.03.010_bib0185","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2967\/jnumed.114.141887","article-title":"Gleason Score at diagnosis predicts the rate of detection of 18F-Choline PET\/CT performed when biochemical evidence indicates recurrence of prostate cancer: experience with 1,000 Patients","volume":"56","author":"Cimitan","year":"2015","journal-title":"J Nucl Med."},{"key":"10.1016\/j.remn.2020.03.010_bib0235","doi-asserted-by":"crossref","first-page":"43S","DOI":"10.2967\/jnumed.115.169755","article-title":"11C- or 18F-Choline PET\/CT for Imaging Evaluation of Biochemical Recurrence of Prostate Cancer","volume":"57","author":"Mapelli","year":"2016","journal-title":"J Nucl Med."},{"key":"10.1016\/j.remn.2020.03.010_bib0195","doi-asserted-by":"crossref","first-page":"833","DOI":"10.2967\/jnumed.112.110148","article-title":"Impact of 18F-Choline PET\/CT in prostate cancer patients with biochemical recurrence: influence of androgen deprivation therapy and correlation with PSA kinetics","volume":"54","author":"Beheshti","year":"2013","journal-title":"J Nucl Med."},{"key":"10.1016\/j.remn.2020.03.010_bib0200","first-page":"156","article-title":"Aportaci\u00f3n de la PET\/TC con 11 C-colina en la recidiva bioqu\u00edmica del c\u00e1ncer de pr\u00f3stata con ant\u00edgeno espec\u00edfico prost\u00e1tico s\u00e9rico inferior a 1ng\/ml","volume":"37","author":"G\u00f3mez-de la Fuente","year":"2017","journal-title":"Rev Esp Med Nucl Imagen Mol."},{"key":"10.1016\/j.remn.2020.03.010_bib0205","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/RLU.0b013e3182867f3c","article-title":"Choline PET or PET\/CT and biochemical relapse of prostate cancer: a systematic review and meta-analysis","volume":"38","author":"Evangelista","year":"2013","journal-title":"Clin Nucl Med."},{"key":"10.1016\/j.remn.2020.03.010_bib0210","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1111\/j.1464-410X.2007.06772.x","article-title":"18F-choline and\/or 11C-acetate positron emission tomography: detection of residual or progressive subclinical disease at very low prostate-specific antigen values (<1ng\/mL) after radical prostatectomy","volume":"99","author":"Vees","year":"2007","journal-title":"BJU Int."},{"key":"10.1016\/j.remn.2020.03.010_bib0215","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.ejrad.2011.01.095","article-title":"Prostate cancer: 1HMRS-DCEMR at 3T versus [(18)F]choline PET\/CT in the detection of local prostate cancer recurrence in men with biochemical progression after radical retropubic prostatectomy (RRP)","volume":"81","author":"Panebianco","year":"2012","journal-title":"Eur J Radiol."},{"key":"10.1016\/j.remn.2020.03.010_bib0220","first-page":"296","article-title":"18F-choline PET\/MRI in suspected recurrence of prostate carcinoma","volume":"37","author":"Riola-Parada","year":"2018","journal-title":"Rev Esp Med Nucl Imagen Mol."},{"key":"10.1016\/j.remn.2020.03.010_bib0225","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1007\/s00259-012-2083-2","article-title":"Clinical impact of 18F-choline PET\/CT in patients with recurrent prostate cancer","volume":"39","author":"Soyka","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"10.1016\/j.remn.2020.03.010_bib0230","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1007\/s00259-010-1496-z","article-title":"PET with 18 F-labelled choline-based tracers for tumour imaging?: a review of the literature","volume":"37","author":"Mertens","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging."}],"container-title":["Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2253654X20300561?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2253654X20300561?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T08:34:03Z","timestamp":1762418043000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2253654X20300561"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S2253654X20300561"],"URL":"https:\/\/doi.org\/10.1016\/j.remn.2020.03.010","relation":{},"ISSN":["2253-654X"],"issn-type":[{"type":"print","value":"2253-654X"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Utilidad diagn\u00f3stica e impacto terap\u00e9utico de la PET\/TC con [18F]F-Fluormetilcolina en la recidiva bioqu\u00edmica del c\u00e1ncer de pr\u00f3stata","name":"articletitle","label":"Article Title"},{"value":"Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.remn.2020.03.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Sociedad Espa\u00f1ola de Medicina Nuclear e Imagen Molecular. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}